A compound for use in the treatment of a disease amelio rated by the inhibition of Notum of formula (I) (2021)

First Author: Fish P. V.
Attributed to:  University College London - Equipment Account funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Type: Other

Volume: U.S. Patent Application No. 17/272,268